Skip to content
P.U. (A)In force

Perintah Racun (Pindaan Senarai Racun) (No. 2) 2019

The full official text, structured for quick navigation. Copy any provision or jump straight to a section.

Enacted
2019
Sections
2

Perintah Racun (Pindaan Senarai Racun) (No. 2) 2019 is Malaysia P.U. (A), cited as P.U. (A) 202 2019, currently marked in force and first recorded in 2019.

Front matterCover and publication detailsOpen

P.U. (A) 202

WARTA KERAJAAN PERSEKUTUAN

FEDERAL GOVERNMENT

GAZETTE

PERINTAH RACUN (PINDAAN SENARAI RACUN)

(NO. 2) 2019

POISONS (AMENDMENT OF POISONS LIST)

(NO. 2) ORDER 2019

DISIARKAN OLEH/

JABATAN PEGUAM NEGARA/

ATTORNEY GENERAL’S CHAMBERS

P.U. (A) 202 2

AKTA RACUN 1952

PERINTAH RACUN (PINDAAN SENARAI RACUN) (NO. 2) 2019

Opening note

Preamble

  1. PADA menjalankan kuasa yang diberikan oleh seksyen 6 Akta Racun 1952 [Akta 366], Menteri, selepas berunding dengan Lembaga Racun, membuat perintah yang berikut: Nama

Perintah ini bolehlah dinamakan Perintah Racun (Pindaan Senarai Racun) (No. 2) 2019.

Pindaan Jadual Pertama

Akta Racun 1952 dipinda dalam Jadual Pertama—

(i)

dalam senarai “Antihistamines; the following:”, dengan memasukkan selepas butiran “Doxylamine” butiran

“Ebastine”;

(ii)

dengan memasukkan selepas butiran “Bretylium; its salts” dan butir-butir yang berhubungan dengannya butiran yang berikut:

P.U. (A) 202 3

Names Part I Part II Exempt

Group A Group B Group C Group D

“Brexpiprazole - All preparations”;

(iii)

dengan memasukkan selepas butiran “Chlorzoxazone” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names Part I

Bahagian II

Part II Exempt

Part II Exempt

Group A Group B Group C Group D

“Cholecalciferol -

All medicinal preparations containing 10,000 i.u. or more of cholecalciferol per dosage unit

All preparations for parenteral administration unless in

Group B

-

-

All preparations unless in Group B or Group C”;

P.U. (A) 202 4

(iv)

dengan memasukkan selepas butiran “Duloxetine; its salts” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Bahagian I

Part I

Bahagian II

Part II

Group A

Group B

Group C

Group D

“Dupilumab

-

All preparations

Durvalumab

-

All preparations”;

(v)

dengan menggantikan butiran

“3,4-Methylenedioxy-methamphetamine

(MDMA)(DD)”

dengan butiran

“3,4-Methylenedioxymethamphetamine (MDMA)(DD)”;

(vi)

dengan memasukkan selepas butiran “Pomalidomide” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Group A

Group B

Group C

Group D

“Ponatinib

-

All preparations”;

P.U. (A) 202 5

(vii)

dengan memasukkan selepas butiran “Santonin” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Group A

Group B

Group C

Group D

“Sapropterin

-

All preparations”; dan

(viii)

dalam senarai “Vitamins; the following:”, dengan memotong butiran “Cholecalciferol”; dan

(i)

dalam senarai “Antihistamines:”, dengan memasukkan selepas butiran “Doxylamine” butiran “Ebastine”;

(ii)

dalam senarai “Antineoplastic agents and Immunosuppressants:”—

(A)

dengan memasukkan selepas butiran “Docetaxel” butiran “Durvalumab”; dan

(B)

dengan memasukkan selepas butiran “Pomalidomide” butiran “Ponatinib”;

P.U. (A) 202 6

(iii)

dalam senarai “Dermatological agents:”, dengan memasukkan selepas butiran “Dithranol” butiran “Dupilumab”;

(iv)

dalam senarai “Tranquillisers:”, dengan memasukkan selepas butiran “Benzquinamide” butiran “Brexpiprazole”;

dan

(v)

dalam senarai “Miscellaneous:”, dengan memasukkan selepas butiran “Sabadilla, alkaloids of” butiran “Sapropterin”.

Dibuat 25 Jun 2019

[KKM.R.600-1/1/56 JLD.

(4)

(9); PN(PU2)172/XVII]

DATUK SERI DR. DZULKEFLY BIN AHMAD

Menteri Kesihatan

P.U. (A) 202 7

POISONS ACT 1952

POISONS (AMENDMENT OF POISONS LIST) (NO. 2) ORDER 2019

Opening note

Preamble

  1. IN exercise of the powers conferred by section 6 of the Poisons Act 1952 [Act 366], the Minister, after consultation with the Poisons Board, makes the following order: Citation 1. This order may be cited as the Poisons (Amendment of Poisons List) (No. 2) Order 2019. Amendment of First Schedule 2. The Poisons Act 1952 is amended in the First Schedule—

(i)

in the list of “Antihistamines; the following:”, by inserting after the item “Doxylamine” the item “Ebastine”;

(ii)

by inserting after the item “Bretylium; its salts” and the particulars relating to it the following item:

P.U. (A) 202 8

Names Part I Part II Exempt

Group A Group B Group C Group D

“Brexpiprazole - All preparations”;

(iii)

by inserting after the item “Chlorzoxazone” and the particulars relating to it the following item:

Name

Group A

Group B

Group C

Group D

“Cholecalciferol -

All medicinal preparations containing 10,000 i.u. or more of cholecalciferol per dosage unit

All preparations for parenteral administration unless in

Group B

-

-

All preparations unless in Group B or Group C”;

P.U. (A) 202 9

(iv)

by inserting after the item “Duloxetine; its salts” and the particulars relating to it the following item:

Names

Group A

Group B

Group C

Group D

“Dupilumab

-

All preparations

Durvalumab

-

All preparations”;

(v)

by substituting for the item

“3,4-Methylenedioxy-methamphetamine

(MDMA)(DD)”

the item

“3,4-Methylenedioxymethamphetamine (MDMA)(DD)”;

(vi)

by inserting after the item “Pomalidomide” and the particulars relating to it the following item:

Names

Group A

Group B

Group C

Group D

“Ponatinib

-

All preparations”;

P.U. (A) 202 10

(vii)

by inserting after the item “Santonin” and the particulars relating to it the following item:

Names

Group A

Group B

Group C

Group D

“Sapropterin

-

All preparations”; and

(viii)

in the list of “Vitamins; the following:”, by deleting the item “Cholecalciferol”; and

(i)

in the list of “Antihistamines:”, by inserting after the item “Doxylamine” the item “Ebastine”;

(ii)

in the list of “Antineoplastic agents and Immunosuppressants:”—

(A)

by inserting after the item “Docetaxel” the item “Durvalumab”; and

(B)

by inserting after the item “Pomalidomide” the item “Ponatinib”;

(iii)

in the list of “Dermatological agents:”, by inserting after the item “Dithranol” the item “Dupilumab”;

P.U. (A) 202 11

(iv)

in the list of “Tranquillisers:”, by inserting after the item “Benzquinamide” the item “Brexpiprazole”; and

(v)

in the list of “Miscellaneous:”, by inserting after the item “Sabadilla, alkaloids of” the item “Sapropterin”.

Made 25 June 2019

[KKM.R.600-1/1/56 JLD.

(4)

(9); PN(PU2)172/XVII]

DATUK SERI DR. DZULKEFLY BIN AHMAD

Minister of Health

Common questions

What is Perintah Racun (Pindaan Senarai Racun) (No. 2) 2019?
Perintah Racun (Pindaan Senarai Racun) (No. 2) 2019 is Malaysia P.U. (A), cited as P.U. (A) 202 2019, currently marked in force and first recorded in 2019.
Is Perintah Racun (Pindaan Senarai Racun) (No. 2) 2019 still in force?
Yes — Perintah Racun (Pindaan Senarai Racun) (No. 2) 2019 is currently in force.
When did Perintah Racun (Pindaan Senarai Racun) (No. 2) 2019 take effect?
Perintah Racun (Pindaan Senarai Racun) (No. 2) 2019 was first recorded in 2019.
How many sections does Perintah Racun (Pindaan Senarai Racun) (No. 2) 2019 have?
Perintah Racun (Pindaan Senarai Racun) (No. 2) 2019 contains 2 sections.
Where can I read the official version of Perintah Racun (Pindaan Senarai Racun) (No. 2) 2019?
The official text of Perintah Racun (Pindaan Senarai Racun) (No. 2) 2019 is published at lom.agc.gov.my.

Something wrong on this page?

If one provision's text doesn't match the official source, use Suggest a fix beside that provision — it opens an editor next to the source document. For anything else — a missing amendment, a broken link, out-of-date content, or a removal request — report it here.